Cargando…

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study

OBJECTIVE: Radioembolisation is generally preceded by a scout dose of technetium-99m-macroaggregated albumin to estimate extrahepatic shunting of activity. Holmium-166 microspheres can be used as a scout dose (±250 MBq) and as a therapeutic dose. The general toxicity of a holmium-166 scout dose ((16...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braat, Arthur J. A. T., Prince, Jip F., van Rooij, Rob, Bruijnen, Rutger C. G., van den Bosch, Maurice A. A. J., Lam, Marnix G. E. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Interventional
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811583/ https://www.ncbi.nlm.nih.gov/pubmed/28786008 http://dx.doi.org/10.1007/s00330-017-4998-2

Ejemplares similares

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
por: van de Maat, Gerrit H., et al.
Publicado: (2012)

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
por: Smits, Maarten L. J., et al.
Publicado: (2019)

Quality of life in patients with liver tumors treated with holmium-166 radioembolization
por: van Roekel, Caren, et al.
Publicado: (2019)

Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022)

(166)Holmium–(99)(m)Technetium dual-isotope imaging: scatter compensation and automatic healthy-liver segmentation for (166)Holmium radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2022)

Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model
por: Vente, M. A. D., et al.
Publicado: (2009)

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

Accuracy of SPECT/CT‐based lung dose calculation for Holmium‐166 hepatic radioembolization before OSEM convergence
por: van Nierop, Bastiaan J., et al.
Publicado: (2018)

Gamma camera characterization at high holmium-166 activity in liver radioembolization
por: Stella, Martina, et al.
Publicado: (2021)

Radioembolisation in Europe: A Survey Amongst CIRSE Members
por: Reinders, Margot T. M., et al.
Publicado: (2018)

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study
por: van Roekel, Caren, et al.
Publicado: (2020)

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel
por: Samim, Morsal, et al.
Publicado: (2017)

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol
por: Andel, Daan, et al.
Publicado: (2023)

Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use
por: Bakker, Robbert C., et al.
Publicado: (2018)

Intratumoral Administration of Holmium-166 Acetylacetonate Microspheres: Antitumor Efficacy and Feasibility of Multimodality Imaging in Renal Cancer
por: Bult, Wouter, et al.
Publicado: (2013)

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
por: Smits, Maarten LJ, et al.
Publicado: (2010)

Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006)

Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs
por: Morsink, Nino Chiron, et al.
Publicado: (2022)

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy
por: Ebbers, Sander C., et al.
Publicado: (2022)

Quantitative (166)Ho-microspheres SPECT derived from a dual-isotope acquisition with (99m)Tc-colloid is clinically feasible
por: Stella, M., et al.
Publicado: (2020)

Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs
por: Vente, M. A. D., et al.
Publicado: (2008)

Case Report: Radioactive Holmium-166 Microspheres for the Intratumoral Treatment of a Canine Pituitary Tumor
por: Morsink, Nino Chiron, et al.
Publicado: (2021)

Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres
por: Roosen, Joey, et al.
Publicado: (2021)

Feasibility of CT quantification of intratumoural (166)Ho-microspheres
por: C. Bakker, R., et al.
Publicado: (2020)

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement
por: van den Hoven, Andor F., et al.
Publicado: (2015)

Comparison of the Biograph Vision and Biograph mCT for quantitative (90)Y PET/CT imaging for radioembolisation
por: Kunnen, Britt, et al.
Publicado: (2020)

Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
por: Drescher, Robert, et al.
Publicado: (2023)

Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma
por: Nouri, Yasir M., et al.
Publicado: (2019)

Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
por: Vermeulen, Sim, et al.
Publicado: (2023)

Radioembolization With Holmium-166 Polylactic Acid Microspheres: Distribution of Residual Activity in the Delivery Set and Outflow Dynamics During Planning and Treatment Procedures
por: Drescher, Robert, et al.
Publicado: (2021)

Additional hepatic (166)Ho-radioembolization in patients with neuroendocrine tumours treated with (177)Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)
por: Braat, Arthur J. A. T., et al.
Publicado: (2018)

Simultaneous (166)Ho/(99m)Tc dual-isotope SPECT with Monte Carlo-based downscatter correction for automatic liver dosimetry in radioembolization
por: van Rooij, R., et al.
Publicado: (2020)

Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects
por: Kühnel, Christian, et al.
Publicado: (2022)

Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis
por: Aarts, Brigit M., et al.
Publicado: (2022)

Therapeutic Effects of Holmium-166 Chitosan Complex in Rat Brain Tumor Model
por: Huh, Ryoong, et al.
Publicado: (2005)

The various therapeutic applications of the medical isotope holmium-166: a narrative review
por: Klaassen, Nienke J. M., et al.
Publicado: (2019)

Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review
por: Lee, Edward Wolfgang, et al.
Publicado: (2016)

First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation
por: Merckel, Laura G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bj5ckjs7hqjk5ce59amhh2cj0p